- Report
- June 2022
- 43 Pages
Global
From €2151EUR$2,450USD£1,871GBP
- Report
- November 2023
- 120 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- December 2024
- 200 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- January 2024
- 200 Pages
Global
From €3643EUR$4,150USD£3,169GBP
- Report
- January 2024
- 200 Pages
Global
From €3643EUR$4,150USD£3,169GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- May 2024
- 289 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- January 2025
- 305 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- July 2024
- 150 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- July 2024
- 100 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- July 2024
- 150 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- July 2024
- 100 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- April 2025
- 70 Pages
Saudi Arabia
From €3072EUR$3,500USD£2,673GBP
- Report
- December 2024
- 85 Pages
India
From €3072EUR$3,500USD£2,673GBP
- Report
- December 2024
- 80 Pages
India
From €3072EUR$3,500USD£2,673GBP
- Report
- November 2024
- 85 Pages
United States
From €3072EUR$3,500USD£2,673GBP
- Report
- February 2024
- 186 Pages
Global
From €3950EUR$4,500USD£3,437GBP
From €3072EUR$3,500USD£2,673GBP
- Report
- July 2024
- 115 Pages
Asia Pacific
From €4169EUR$4,750USD£3,627GBP
- Report
- July 2024
- 110 Pages
From €4169EUR$4,750USD£3,627GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more